참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Sodium periodate | HCID 23667635 | — |
| 반응물 | 3-Isopropyl-6-vinyl-[1,2,4]triazolo[4,3-b]pyridazine | HCID 57929891 | — |
| 촉매 | Osmium Tetroxide | HCID 30318 | — |
| 용매 | Water | HCID 962 | — |
| 용매 | 1,4-Dioxane | HCID 31275 | — |
| 생성물 | 3-Isopropyl-[1,2,4]triazolo[4,3-b]pyridazine-6-carbaldehyde | HCID 57929899 | 69.5% |
반응 단계
The 3-isopropyl-6-vinyl-[1,2,4]triazolo[4,3-b]pyridazine (3.28 g, 17.4 mmol, Preparation #1) in 1,4-dioxane (75 mL) and water (15 mL) was treated with osmium tetroxide (3.5 mL, 0.28 mmol, 2.5 wt % in 2-methyl 1-propanol) and then sodium periodate (7.45 g, 34.9 mmol) was added. The mixture was stirred at ambient temperature for about 1 h and then diluted with 1,4-dioxane (50 mL) and filtered through Celite®. The filter cake was washed with 1,4-dioxane then EtOAc. The filtrate was concentrated under reduced pressure and then the residue was purified by flash chromatography on silica gel with DCM/MeOH (9:1) as an eluent to give the title compound (2.30 g, 69.4%) as a beige solid: 1H NMR (CDCl3) δ 1.61 (d, 6H), 3.76 (m, 1H), 7.65 (d, 1H), 8.21 (m, 1H), 10.06 (d, 1H).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US08188083B2 |
|---|
| 출처 데이터셋 | uspto-grants-2012_05 |
|---|
| ORD ID | ord-dc966c3ffdd04a069d734e43f2865962 |
|---|
| 출처 메모 | uspto-grants-2012_05 |
|---|